Uchida A, Moore M, Klein E
Department of Radiation System Biology, Kyoto University, Japan.
Int J Cancer. 1988 May 15;41(5):651-6. doi: 10.1002/ijc.2910410502.
The specific and non-specific nature of autotumor cytotoxicity induced in autologous mixed lymphocyte-tumor culture (AMLTC) and autologous mixed lymphocyte culture (AMLC) was studied in patients with carcinomatous pleural effusions. Small- and medium-sized blood lymphocytes that were isolated by centrifugation on discontinuous Percoll gradients did not lyse autologous, freshly isolated effusion tumor cells. In vitro activation of the small lymphocytes, but not of the medium lymphocytes, with autologous tumor cells generated cytotoxic potential restricted to autologous tumor. When stimulated with autologous non-malignant non-T cells, the medium lymphocytes, but not small lymphocytes, were triggered to cytotoxicity that acted not only on autologous tumor cells but also on allogeneic tumor cells, T blasts, and tumor cell lines. Experiments using monoclonal antibodies (MAb) and complement (C') showed that both types of killer cells were CD2+ CD3+ CD16- T cells. Autotumor cytotoxicity developed in AMLTC was mediated by the CD4- CD8+ T cell subset in 6 of 9 cases and the CD4+ CD8- subset in the other 3 cases. In contrast, cytotoxicity induced in AMLC was exerted exclusively by the CD8+ subset. The enrichment of blasts from cultured T cells on discontinuous density gradients enhanced autotumor killing activity, with no reactivity recorded for blast-depleted, resting T cells. Addition of mitomycin-C-treated large granular lymphocytes (LGL) to AMLTC abolished the induction of autotumor killer cells, whereas non-specific killer cells were generated in AMLC irrespective of the presence of LGL. These results indicate that stimulation of autoreactive T cells in AMLTC and in AMLC could induce 2 distinct types of autotumor killer cells.
对癌性胸腔积液患者自体混合淋巴细胞-肿瘤培养(AMLTC)和自体混合淋巴细胞培养(AMLC)中诱导的自体肿瘤细胞毒性的特异性和非特异性性质进行了研究。通过在不连续的Percoll梯度上离心分离得到的小和中等大小的血液淋巴细胞不会裂解自体新鲜分离的胸腔积液肿瘤细胞。用自体肿瘤细胞对小淋巴细胞而非中等淋巴细胞进行体外激活产生了仅限于自体肿瘤的细胞毒性潜能。当用自体非恶性非T细胞刺激时,中等淋巴细胞而非小淋巴细胞被触发产生细胞毒性,这种细胞毒性不仅作用于自体肿瘤细胞,还作用于同种异体肿瘤细胞、T母细胞和肿瘤细胞系。使用单克隆抗体(MAb)和补体(C')的实验表明,两种类型的杀伤细胞均为CD2 + CD3 + CD16 - T细胞。AMLTC中产生的自体肿瘤细胞毒性在9例中有6例由CD4 - CD8 + T细胞亚群介导,另外3例由CD4 + CD8 - 亚群介导。相比之下,AMLC中诱导的细胞毒性仅由CD8 + 亚群发挥。通过在不连续密度梯度上对培养的T细胞中的母细胞进行富集增强了自体肿瘤杀伤活性,而对于去除母细胞的静止T细胞未记录到反应性。向AMLTC中添加丝裂霉素-C处理的大颗粒淋巴细胞(LGL)消除了自体肿瘤杀伤细胞的诱导,而无论LGL是否存在,AMLC中都会产生非特异性杀伤细胞。这些结果表明,在AMLTC和AMLC中对自身反应性T细胞的刺激可诱导2种不同类型的自体肿瘤杀伤细胞。